Clinical Trial Update: COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for COVID-19 convalescent plasma in hospitalized pneumonia due to SARS-CoV-2; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• COVID-19 convalescent plasma

Snippet

Sponsor: University of Pennsylvania | Conditions: COVID-19 | Phase 1 | Status: COMPLETED | Results posted: 2022-04-19